Maternal infection with Schistosoma japonicum induces a profibrotic response in neonates

Infection and Immunity

Volumn 82, Issue 1, 2014, Pages 350-355

  McDonald, Emily A ^a,b   Cheng, Ling ^a,b   Jarilla, Blanca ^c   Sagliba, Marianne J ^c   Gonzal, Annaliza ^c   Amoylen, Amabelle J ^c   Olveda, Remigio ^c   Acosta, Luz ^a,c   Baylink, David ^d   White, Eric S ^e   Friedman, Jennifer F ^a,b   Kurtis, Jonathan D ^a,b  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

^d LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 6; CONNECTIVE TISSUE GROWTH FACTOR; DESMOSINE; GELATINASE A; GROWTH FACTOR; PROCOLLAGEN; PROCOLLAGEN TYPE I CARBOXYTERMINAL PROPEPTIDE; SOMATOMEDIN C; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FIBROSIS; HUMAN; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MATERNAL DISEASE; NEWBORN; NONHUMAN; PHILIPPINES; PREGNANCY; PREMATURITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS; UMBILICAL CORD BLOOD;

EID: 84890838835     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01060-13     Document Type: Article

References (40)

1. Friedman JF, Mital P, Kanzaria H, Olds G, Kurtis J. 2007. Schistosomiasis and pregnancy. Trends Parasitol. 23:159-164. http://dx.doi.org/10.1016/j.pt.2007.02.006.
2. King C. 2010. Parasites and poverty: the case of schistosomiasis. Acta Trop. 113:95-104. http://dx.doi.org/10.1016/j.actatropica.2009.11.012.
3. Arnaud V, Li J, Wang Y, Fu X, Mengzhi S, Luo X, Hou X, Dessein H, Jie Z, Xin-Ling Y, He H, McManus DP, Li Y, Dessein A. 2008. Regulatory role of interleukin-10 and interferon-gamma in sever hepatic central and peripheral fibrosis in humans infected with Schistosoma japonicum. J. Infect. Dis. 198:418-426. http://dx.doi.org/10.1086/588826.
4. Coutinho H, McGarvey ST, Acosta L, Manalo D, Langdon G, Leenstra T, Kanzaria H, Solomon J, Wu H-W, Olveda R, Kurtis J, Friedman JF. 2005. Nutritional status and serum cytokine profiles in children, adolescents, and young adults with Schistosoma japonicum-associated hepatic fibrosis, in Leyte, Philippines. J. Infect. Dis. 192:528-536. http://dx.doi.org/10.1086/430929.
5. Coutinho H, Acosta L, Wu H, McGarvey ST, Langdon G, Jiz M, Jarilla B, Olveda R, Friedman JF, Kurtis J. 2007. Th2 cytokines are associated with persistent hepatic fibrosis in human Schistosoma japonicum infection. J. Infect. Dis. 195:288-295. http://dx.doi.org/10.1086/510313.
6. Cheever A, Williams M, Wynn TA, Finkelman F, Seder R, Cox T, Hieny S, Caspar P, Sher A. 1994. Anti-IL-4 treatment of Schistosoma mansoniinfected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J. Immunol. 153:753-759.
7. Chiaramonte M, Donaldson D, Cheever A, Wynn TA. 1999. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J. Clin. Invest. 104:777-785. http://dx.doi.org/10.1172/JCI7325.
8. Wynn TA, Ramalingam T. 2012. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 18:1028-1040. http://dx.doi.org/10.1038/nm.2807.
9. Fabre V, Wu H-W, PondTor S, Coutinho H, Acosta L, Jiz M, Olveda R, Cheng L, White E, Jarilla B, McGarvey ST, Friedman JF, Kurtis J. 2011. Tissue inhibitor of matrix-metalloprotease-1 predicts risk of hepatic fi-brosis in human Schistosoma japonicum infection. J. Infect. Dis. 203:707-714. http://dx.doi.org/10.1093/infdis/jiq099.
10. Kurtis JD, Higashi A, Wu H-W, Gundogan F, McDonald EA, Sharma S, PondTor S, Jarilla B, Sagliba MJ, Gonzal A, Olveda R, Acosta L, Friedman JF. 2011. Maternal schistosomiasis japonica is associated with maternal, placental, and fetal inflammation. Infect. Immun. 79:1254-1261. http://dx.doi.org/10.1128/IAI.01072-10.
11. Attallah A, Ghanem G, Ismail H, El Waseef A. 2003. Placental and oral delivery of Schistosoma mansoni antigen from infected mothers to their newborns and children. Am. J. Trop. Med. Hyg. 68:647-651.
12. Malhotra I, Ouma J, Wamachi A, Kioko J, Mungai P, Omollo A, Elson L, Koech D, Kazura J, King C. 1997. In utero exposure to helminth and mycobacterial antigens generates cytokine responses similar to that observed in adults. J. Clin. Invest. 99:1759-1766. http://dx.doi.org/10.1172/JCI119340.
13. Romia S, Handoussa A, Youseff S, El Zayat M. 1992. Transplacental transfer of schistosomal antigens and antibodies. J. Egypt Soc. Parasitol. 22:575-582.
14. Hassan M, Hassounah O, Hegab M, Salah K, el-Mahrouky L, Galal N. 1997. Transmission of circulating schistosomal antigens from infected mothers to their newborns. J. Egypt Soc. Parasitol. 27:773-780.
15. Siegrist D, Siegrist-Obimpeh P. 1992. Schistosoma haematobium infection in pregnancy. Acta Trop. 50:317-321. http://dx.doi.org/10.1016/0001-706X(92)90066-7.
16. Carlier Y, Nzeyimana H, Bout D, Capron A. 1980. Evaluation of circulating antigens by a sandwich radioimmunoassay, and of antibodies and immune complexes, in Schistosoma mansoni-infected African parturients and their newborn children. Am. J. Trop. Med. Hyg. 29:74-81.
17. Tachon P, Borojevic R. 1978. Mother-child relation in human schistosomiasis mansoni: skin test and cord blood reactivity to schistosomal antigens. Trans. R. Soc. Trop. Med. Hyg. 72:605-609. http://dx.doi.org/10.1016/0035-9203(78)90011-1.
18. Friedman JF, Kanzaria H, Acosta L, Langdon G, Manalo D, Wu H-W, Olveda R, McGarvey ST, Kurtis J. 2005. Relationship between Schistosoma japonicum and nutritional status among children and young adults in Leyte, the Philippines. Am. J. Trop. Med. Hyg. 72:527-533.
19. WHO. 1987. Prevention and control of intestinal parasitic infections. World Health Organ. Tech. Rep. Ser. 749:1-86.
20. Ballard J, Novak K, Driver M. 1979. A simplified score for assessment of fetal maturation of newly born infants. J. Pediatr. 95:769-774. http://dx.doi.org/10.1016/S0022-3476(79)80734-9.
21. Williams R, Creasy R, Cunningham G, Hawes W, Norris F, Tashiro M. 1982. Fetal growth and perinatal viability in California. Obstet. Gynecol. 59:624-632.
22. Lijnen P, Maharani T, Finahari N, Prihadi J. 2012. Serum collagen markers and heart failure. Cardiovasc. Hematol. Disord. Drug Targets 12:51-55. http://dx.doi.org/10.2174/187152912801823147.
23. Krein P, Winston B. 2002. Roles for insulin-like growth factor I and transforming growth factor-beta in fibrotic lung disease. Chest 122:289S-293S. http://dx.doi.org/10.1378/chest.122.6_suppl.289S.
24. Franklin T. 1997. Therapeutic approaches to organ fibrosis. Int. J. Biochem. Cell Biol. 29:79-89. http://dx.doi.org/10.1016/S1357-2725(96)00121-5.
25. Shahin M, Schuppan D, Waldherr R, Risteli J, Risteli L, Savolainen E, Oesterling C, Abdel Rahman H, el Sahly A, Abdel Razek S. 1992. Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease. Hepatology 15:637-644. http://dx.doi.org/10.1002/hep.1840150414.
26. Gomez D, De Lorenzo M, Alonso D, Andrade Z. 1999. Expression of metalloproteinases (MMP-1, MMP-2, and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in schistosomal portal fibrosis. Am. J. Trop. Med. Hyg. 61:9-13.
27. Hassan A, Abd el Moneim M, Abd el Aal A, Abou Aly S, Ahmed S, Sollman A, el Kersh M. 1991. Circulating growth hormone, insulin-like growth factor I, cortisol and free thyroxine in children with schistosomiasis with and without hepatic fibrosis. J. Trop. Pediatr. 37:25-30. http://dx.doi.org/10.1093/tropej/37.1.25.
28. Willingham AL, III, Johansen AM, Bøgh H, Ito A, Andreassen J, Lindberg R, Christensen N, Nansen P. 1999. Congenital transmission of Schistosoma japonicum in pigs. Am. J. Trop. Med. Hyg. 60:311-312.
29. Seydel L, Petelski A, van Dam G, van der Kleij D, Kruize-Hoeksma Y, Luty A, Yazdanbakhsh M, Kremsner P. 2012. Association of in utero sensitization to Schistosoma haematobium with enhanced cord blood IgE and increased frequencies of CD5+ B cells in African newborns. Am. J. Trop. Med. Hyg. 86:613-619. http://dx.doi.org/10.4269/ajtmh.2012.11-0463.
30. Hsiang M, Carlton E, Zhang YL, Zhong B, Dongchuan Q, Cohen P, Stewart C, Spear R. 2010. Use of ultrasonography to evaluate Schistosoma japonicum-related morbidity in children, Sichuan Province, China, 2000-2007. Am. J. Trop. Med. Hyg. 82:103-111. http://dx.doi.org/10.4269/ajtmh.2010.09-0061.
31. Olveda R, Daniel B, Ramirez B, Aligui G, Acosta L, Fevidal P, Tiu E, de Veyra F, Peters P, Romulo R, Domingo E, Wiest P, Olds G. 1996. Schistosomiasis japonica in the Philippines: the long-term impact of population-based chemotherapy on infection, transmission, and morbidity. J. Infect. Dis. 174:163-172. http://dx.doi.org/10.1093/infdis/174.1.163.
32. Wiest P, Wu G, Zhong S, McGarvey ST, Tan E, Yuan J, Peters P, Olveda R, Olds G. 1993. Schistosomiasis japonica on Jishan Island, Jiangxi Province, People's Republic of China: persistence of hepatic fibrosis after reduction of the prevalence of infection with age. Trans. R. Soc. Trop. Med. Hyg. 87:290-294. http://dx.doi.org/10.1016/0035-9203(93)90133-B.
33. El Scheich T, Hofer L, Kaatano G, Foya J, Odhiambo D, Igogote J, Lwambo N, Ekamp H, Karst K, Häussinger D, Richter J. 2012. Hepatosplenic morbidity due to Schistosoma mansoni in schoolchildren on Ukerewe Island, Tanzania. Parasitol. Res. 110:2515-2520. http://dx.doi.org/10.1007/s00436-011-2793-6.
34. Strahan R, Chiyesu K, Schneider-Kolsky M. 2012. Ultrasound study of liver disease caused by Schistosoma mansoni in rural Zambian schoolchildren. J. Med. Imaging Radiat. Oncol. 56:390-397. http://dx.doi.org/10.1111/j.1754-9485.2012.02371.x.
35. Siebold-Weiger K, Wollmann H, Ranke M, Speer C. 2000. Plasma concentrations of the carboxyterminal propeptide of type I procollagen (PICP) in preterm neonates from birth to term. Pediatr. Res. 48:104-108. http://dx.doi.org/10.1203/00006450-200007000-00018.
36. Nakano K, Iwamatsu T, Wang C, Tarasima M, Nakayama T, Sasaki K, Tachikawa E, Noda N, Mizoguchi E, Osawa M. 2006. High bone turnover of type I collagen depends on fetal growth. Bone 38:249-256. http://dx.doi.org/10.1016/j.bone.2005.07.017.
37. Sundrani D, Chavan-Gautam P, Pisal H, Mehendale S, Joshi S. 2013. Matrix metalloproteinases-2, and-3 and tissue inhibitors of metalloproteinases-1,-2 in placentas from preterm pregnancies and their association with one-carbon metabolites. Reproduction 145:401-410. http://dx.doi.org/10.1530/REP-12-0520.
38. Skogstrand K, Hougaard D, Schendel D, Bent N, Svaerke C, Thorsen P. 2008. Association of preterm birth with sustained postnatal inflammatory response. Obstet. Gynecol. 111:1118-1128. http://dx.doi.org/10.1097/AOG.0b013e31817057fb.
39. Yasumizu T, Kato J. 1996. Concentrations of serum markers of type I collagen synthesis and degradation and serum osteocalcin in maternal and umbilical circulation. Endocr. J. 43:191-195. http://dx.doi.org/10.1507/endocrj.43.191.
40. Oh S, Song S, Seo E, Kim K, Choi S, Suh Y, Sadovsky Y, Roh C. 2009. The expression of connective tissue growth factor in pregnancies complicated by severe preeclampsia or fetal growth restriction. Placenta 30:981-987. http://dx.doi.org/10.1016/j.placenta.2009.08.006.